examples:

# =========================================================
# EXAMPLE 1 — CONTINUOUS OUTCOMES (din första text)
# =========================================================
- text: |
    Mean body weight gain: WGJ +50.6 g vs WA -0.7 g (n=30 per arm).
  output: |
    {
      "extractions": [
        {
          "outcome": "Mean body weight gain",
          "intervention": "WGJ",
          "comparator": "WA",
          "intervention_mean": 50.6,
          "intervention_group_size": 30,
          "comparator_mean": -0.7,
          "comparator_group_size": 30
        }
      ]
    }

# =========================================================
# EXAMPLE 2 — CONTINUOUS OUTCOME WITH MEAN ± SD (från din text)
# =========================================================
- text: |
    Duration of illness (h): AJ 49.4 ± 32.6, WGJ 47.5 ± 38.9, WA 26.5 ± 27.4 (n=30/arm).
  output: |
    {
      "extractions": [
        {
          "outcome": "Duration of illness (h)",
          "intervention": "WGJ",
          "comparator": "WA",
          "intervention_mean": 47.5,
          "intervention_standard_deviation": 38.9,
          "intervention_group_size": 30,
          "comparator_mean": 26.5,
          "comparator_standard_deviation": 27.4,
          "comparator_group_size": 30
        }
      ]
    }

# =========================================================
# EXAMPLE 3 — BINARY OUTCOMES (från din text)
# =========================================================
- text: |
    At week 8, CGI-I response rates were 78.2% (79/101) for fluoxetine, 68.7% (68/99) for desvenlafaxine, and 62.6% (62/99) for placebo.
  output: |
    {
      "extractions": [
        {
          "outcome": "CGI-I response rate",
          "intervention": "fluoxetine",
          "comparator": "placebo",
          "intervention_events": 79,
          "intervention_group_size": 101,
          "comparator_events": 62,
          "comparator_group_size": 99
        },
        {
          "outcome": "CGI-I response rate",
          "intervention": "desvenlafaxine",
          "comparator": "placebo",
          "intervention_events": 68,
          "intervention_group_size": 99,
          "comparator_events": 62,
          "comparator_group_size": 99
        }
      ]
    }
